Lipoprotein lipase activity is decreased in a large cohort of patients with coronary artery disease and is associated with changes in lipids and lipoproteins

Journal of Lipid Research

Volumn 40, Issue 4, 1999, Pages 735-743

  Henderson, Howard E ^a,b   Kastelein, John J P ^a,c   Zwinderman, Aeilko H ^d   Gagné, Eric ^a   Jukema, J Wouter ^e   Reymer, Paul W A ^e   Groenemeyer, Björn E ^f   Lie, Kong I ^c   Bruschke, Albert V G ^e   Hayden, Michael R ^a   Jansen, Hans ^g  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b UNIVERSITY OF CAPE TOWN   (South Africa)

^c UNIVERSITY OF AMSTERDAM   (Netherlands)

^d LEIDEN UNIVERSITY   (Netherlands)

^e LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^f ROYAL NETHERLANDS ACADEMY OF ARTS AND SCIENCES   (Netherlands)

^g ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

Author keywords

Cholesterol; HDL; LDL; REGRESS study; Triglyceride; VLDL

Indexed keywords

CHOLESTEROL; HIGH DENSITY LIPOPROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; LIPOPROTEIN; LIPOPROTEIN LIPASE; LOW DENSITY LIPOPROTEIN; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; ARTICLE; ATHEROSCLEROSIS; CONTROLLED STUDY; CORONARY ARTERY DISEASE; ENZYME ACTIVITY; ENZYME DEFICIENCY; GENE MUTATION; GENOTYPE; HUMAN; LIPID METABOLISM; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

ADULT; APOLIPOPROTEINS E; CHOLESTEROL; COHORT STUDIES; CORONARY DISEASE; DOUBLE-BLIND METHOD; FASTING; HUMANS; LIPIDS; LIPOPROTEIN LIPASE; LIPOPROTEINS; MALE; MIDDLE AGED; MUTATION; PLACEBOS; REFERENCE VALUES; TRIGLYCERIDES;

EID: 0032914885     PISSN: 00222275     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (60)

1. Miesenbock, G., B. Holzl, B. Foger, E. Brandstatter, B. Paulweber, F. Sandhofer, and J. R. Patsch. 1993. Heterozygous lipoprotein lipase deficiency due to a missense mutation as the cause of impaired triglyceride tolerance with multiple lipoprotein abnormalities. J. Clin. Invest. 91: 448-455.
2. Wilson, D. E., M. Emi, P. H. Iverius, A. Hata, L. L. Wu, W. Hillas, R. R. Williams, and J. M. Lalouel. 1990. Phenotypic expression of heterozygous lipoprotein lipase deficiency in the extended pedigree of a proband homozygous for a missense mutation. J. Clin. Invest. 86: 735-750.
3. Bijvoet, S., S. E. Gagne, S. Moorjani, C. Gagne, H. E. Henderson, J. C. Fruchart, J. Dallongeville, P. Alaupovic, M. Prins, J. J. P. Kastelein, and M. R. Hayden. 1996. Alterations in plasma lipoproteins and apolipoproteins before the age of 40 in heterozygotes for lipopiotein lipase deficiency. J. Lipid Res. 37: 640-650.
4. Sprecher, D. L., B. V. Harris, E. A. Stein, P. S. Bellet, L. M. Keilson, and L. A. Simbartl. 1996. Higher triglycerides, lower high-density cholesterol, and higher systolic blood pressure in lipoprotein lipase-deficient heterozygotes. A preliminary report. Circulation. 94: 3239-3245.
5. Nordestgaard, B. G., S. Abildgaard, H. H. Wittrup, R. Steffensen, G. Jensen, and A. Tybjaerg-Hansen. 1997. Heterongous lipoprotein lipase deficiency: fiequency in the general population, effect on plasma lipid levels and risk of ischemic heart disease. Circulation. 96: 1737-1744.
6. Jackson, R. L., M. T. Yates, C. A. McNerney, and M. L. Kashyap. 1990. Relationship between post-heparin plasma lipases, triglycerides and high density lipoproteins in normal subjects. Horm. Metab. Res. 22: 289-294.
7. Kekki, M. 1980. Lipoprotein-lipase action determining plasma high density lipoprotein cholesterol level in adult normolipaemics. Atherosclerosis. 37: 143-150.
8. Glaser, D. S., T. J. Yost, and R. H. Eckel. 1992. Preheparin lipoprotein lipolytic activities: relationship to plasma lipoproteins and postheparin lipolytic activities. J. Lipid Res. 33: 209-214.
9. Lamarche, B., J. P. Despres, M. C. Pouliot, S. Moorjani, P. J. Lupien, G. Theriault, A. Tremblay, A. Nadeau, and C. Bouchard. 1992. Is body fat loss a determinant factor in the improvement of carbohydrate and lipid metabolism following aerobic exercise training in obese women?. Metab. Clin. Exp. 41: 1249-1256.
10. Kuusi, T., Y. A. Kesaniemi, M. Vuoristo, T. A. Miettinen, and M. Koskenvuo. 1987. Inheritance of high density lipoprotein and lipoprotein lipase and hepatic lipase activity. Arteriosclerosis. 7: 421-425.
11. Taskinen, M. R., and E. A. Nikkila. 1980. Effect of acute vigorous exercise on lipoprotein lipase activity of adipose tissue and skeletal muscle in physically active men. Artery. 6: 471-483.
12. Kuusi, T., C. Ehnholm, J. Viikari, R. Harkonen, E. Vartiainen, P. Puska, and M. R. Taskinen. 1989. Postheparin plasma lipoprotein and hepatic lipase are determinants of hypo-and hyperalphalipoproteinemia. J. Lipid Res. 30: 1117-1126.
13. St. Amand, J., S. Moorjani, P. J. Lupien, D. Prud'Homme, and J. P. Despres. 1996. The relation of plasma triglyceride, apolipoprotein B, and high-density lipoprotein cholesterol to postheparin lipoprotein lipase activity is dependent on apolipoprotien E polymorphism. Metab. Clin. Exp. 45: 261-267.
14. Huttunen, J. K., C. Ehnholm, M. Kekki, and K. A. Nikkila. 1976. Post-heparin plasma lipoprotein lipase and hepatic lipase in normal subjects and in patients with hypertriglyceridaemia: correlations to sex, age and various parameters of triglyceride metabolism. Clin. Sci. Mol. Med. 50: 249-260.
15. Pollare, T., B. Vessby, and H., Lithel. 1991. Lipoprotein lipase activity in skeletal muscle is related to insulin sensitivity. Arterioscler. Thromb. 11: 1192-1203.
16. Mailly, F., Y. Tugrul, P. W. Reymer, T. Bruin, M. Seed, B. E. Groenemeyer, A. Asplund-Carlson, D. Vallance, A. F. Winder, G. J. Miller, J. J. P. Kastelein, A. Hampsten, G. Olivecrona, S. E. Humphries, and P. Talmud. 1995. A common variant in the gene for lipoprotein lipase (Asp9→Asn). Functional implications and prevalence in normal and hyperlipidemic subjects. Arterioscler. Thromb. Vasc. Biol. 15: 468-478.
17. Boberg, J., 1972. Heparin-released blood plasma lipoprotein lipase activity in patients with hyperlipoproteinemia. Acta. Med. Scand. 191:97-102.
18. Alvarez, J. J., A. Montelongo, A. Iglesias, M. A. Lasuncion, and E. Herrera. 1996. Longitudinal study on lipoprotein profile, high density lipoprotein subclass, and postheparin lipases during gestation in women. J. Lipid Res. 37: 299-308.
19. Couillard, C., N. Bergeron, D. Prud'homme, J. Bergeron, A. Trembly, C. Bouchard, P. Mauriege, and J. P. Despre. 1998. Postprandial triglyceride response in visceral obesity in men. Diabetes. 47: 953-960.
20. Taskinen, M. R., C. J. Glueck, M. L. Kashyap, L. S. Srivastava, B. A. Hynd, G. Perisutti, K. Robinson, P. J. Kinnunen, and T. Kuusi. 1980. Post-heparin plasma lipoprotein and hepatic lipases. Relationships to high density lipoprotein cholesterol and to apolipoprotein CII in familial hyperalplialipoproteinemic and in normal subjects. Atherosclerosis. 37: 247-256.
21. Applebaum-Bowden, D., S. M. Haffner, P. W. Wahl, J. J. Hoover, G. R. Warnick, J. J. Albers, and W. R. Hazzard. 1985. Postheparin plasma triglyceride lipases. Relationships with very low density lipoprotein triglyceride and high density lipoprotein2 cholesterol. Arteriosclerosis. 5: 273-282.
22. St. Amand, J., J. P. Despres, S. Lemieux, B. Lamarche, S. Moorjani, A. Prud'homme, C. Bouchard, and P. J. Lupien. 1995. Does lipoprotein or hepatic lipase activity explain the protective lipoprotein profile of premenopausal women?. Metab. Clin. Exp. 44:491-498.
23. Kuusi, T., E. A. Nikkila, P. Saarinen, P. Varjo, and L. A. Laitinen. 1982. Plasma high density lipoproteins HDL2, HDL3 and postheparin plasma lipases in relation to parameters of physical fitness. Atherosclerosis. 41: 209-219.
24. Peltonen, P., J. Marniemi, E, E. Hietanen, I. Vuori, and C. Ehnholm. 1981. Changes in serum lipids, lipoproteins, and heparin releasable lipolytic enzymes during moderate physical training in man: a longitudinal study. Metab. Clin. Exp. 30: 518-526.
25. Knudsen, P., S. Murtomaki, M. Antikainen, S. Ehnholm, C. Ehnholm, and M. R. Taskinen. 1997. The Asn291→Ser and Ser447→ stop mutations of the lipoprotein lipase gene and their significance for lipid metabolism in patients with hypertriglyceridemia. Eur. J. Clin. Invest. 27: 928-935.
26. Zhang, H., H. E. Henderson, E. Gagne, S. M. Clee, L. Miao, G. Liu, and M. R. Hayden. 1996. Common sequence variants of lipoprotein lipase: standardized studies of in vitro expression and catalytic function. Biochim. Biophys. Acta. 1302: 159-166.
27. Ma, Y., T. C. Ooi, M. S. Liu, H. Zhang, R. McPherson, A. L. Edwards, I. J. Forsythe, J. Frohlich, J. D. Brunzell, and M. R. Hayden. 1994. High frequency of mutations in the human lipoprotein lipase gene in pregnancy-induced chylomicronemia: possible association with apolipoprotein E2 isoform. J. Lipid Res. 35: 1066-1075.
28. Busca, R., J. Peinado, E. Vilella. J. Auwerx, S. S. Deeb, S. Vilaro, and M. Reina. 1995. The mutant Asn291 →Ser human lipoprotein lipase is associated with reduced catalytic activity and does not influence binding to heparin. FEBS Lett. 367: 257-262.
29. Jukema, J. W., A. V. Bruschke, A. J. van Boven, J. H. Reiber, E. T. Bal, A. H. Zwinderman, H. Jansen, G. J. Boerma, F. M. van Rappard, and K. I. Lie. 1995. Effects of lipid lowering by pravastatin on progression and regression of coronary artery disease in symptomatic men with normal to moderately elevated serum cholesterol levels. The Regression Growth Evaluation Statin Study (REGRESS). Circulation. 91: 2528-2540.
30. Friedewald, W. T., R. I. Levy, and D. S. Fredrickson. 1972. Estimation of the concentration of low density lipoprotein cholesterol in plasma without use of the preparative ultracentrifuge. Clin. Chem. 18: 499-502.
31. Ma, Y., M. S. Liu, H. Zhang, I. J. Forsythe, J. D. Brunzell, and M. R. Hayden. 1993. A 4 basepair deletion in exon 4 of the human lipoprotein lipase gene results in type I hyperlipoproteinemia. Hum. Mol. Genet. 2: 1049-1050.
32. Groenemeijer, B. E., M. D. Hallman, P. W. Reymer, E. Gagne, J. A. Kuivenhoven, T. Bruin, H. Jansen, K. I. Lie, A. V. Bruschke, E. Boerwinkle, M. R. Hayden, and J. J. P. Kastelein. 1997. Genetic variant showing a positive interaction with beta-blocking agents with a beneficial influence on lipoprotein lipase activity, HDL cholesterol, and triglyceride levels in coronary artery disease patients. The Ser447-stop substitution in the lipoprotein lipase gene. REGRESS Study Group. Circulation. 95: 2628-2635.
33. Hixson, J. E., and D. T. Vernier. 1990. Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI. J. Lipid Res. 31: 545-548.
34. Hokanson, J. E. 1997. Lipoprotein lipase gene variants and the risk of coronary disease: a quantitative analysis of population-based studies. Int. J. Clin. Lab. Res. 27: 24-34.
35. Elbein, S. C., C. Yeager, L. K. Kwong, A. Lingam, I. Inoue, J. M. Lalouel, and D. E. Wilson. 1994. Molecular screening of the lipoprotein lipase gene in hypertriglyceridemic members of familial noninsulin-dependent diabetes mellitus families. J. Clin. Endocrin. Metab. 79: 1450-1456.
36. Hata, A., M. Robertson, M. Emi, and J. M. Lalouel. 1990. Direct detection and automated sequencing of individual alleles after electrophoretic strand separation: identification of a common nonsense mutation in exon 9 of the human lipoprotein lipase gene. Nucleic Acids Res. 18: 5407-5411.
37. Yang, W-S., D. N. Nevin, R. Peng, J. D. Brunzell, and S. S. Deeb. 1992. A mutation in the promoter of the lipoprotein lipase (LPL) gene in a patient with a familial combined hyperlipoproteinemia and low LPL activity. Prof. Natl. Acad. Sci. USA. 92: 4462-4466.
38. Gagne, E., J. J. Genest, H. Zhang, L. A. Clarke, and M. R. Hayden. 1994. Analysis of DNA changes in the LPL gene in patients with familial combined hyperlipidemia. Arterioscler. Thromb. 14: 1250-1257.
39. Karpe, F., P. Tornvall, T. Olivecrona, G. Steiner, L. A. Carlson, and A. Hamsten. 1993. Composition of human low density lipoprotein: effects of postprandial triglyceride-rich lipoproteins, lipoprotein lipase, hepatic lipase and cholesteryl ester transfer protein. Atherosclerosis. 98: 33-49.
40. Zambon, A., M. A. Austin, B. G. Brown, J. E. Hokanson, and J. D. Brunzell. 1993. Effect of hepatic lipase on LDL in normal men and those with coronary artery disease. Arterioscler. Thromb. 13: 147-153.
41. Katzel, L. I., P. J. Coon, M. J. Busby, S. O. Gottlieb, R. M. Krauss, and A. P. Goldberg. 1992. Reduced HDL2 cholesterol subspecies and elevated postheparin hepatic lipase activity in older men with abdominal obesity and asymptomatic myocardial ischemia. Arterioscler. Thromb. 12: 814-823.
42. Kihara, S., M. Knbo, N. Ikeda, S. Yokoyama, Y. Matsusawa, S. Tauri, A. Yamamoto, and K. Y. Hostetler 1989. Inhibition of post-heparin lipoprotein lipase by beta-adrenergic blockers in vitro. Biochim. Pharmacol. 38:407-411.
43. Day, J. L., J. Metcalfe, N. Simpson, and L. Lowenthal. 1984. Adrenergic mechanisms in the control of plasma lipids in man. Am. J. Med. 76: 94-96.
44. Cohn, J. S., J. R. McNamara, S. D. Cohn, J. M. Ordovas, and E. J. Schaefer. 1988. Postprandial plasma lipoprotein changes in human subjects of different ages. J. Lipid Res. 29: 469-479.
45. Zambon, A., and J. E. Hokansen. 1998. Lipoprotein classes and coronary disease regression. Curr. Opin. Lipidol. 9: 329-336.
46. Ooi, T.C., E. Simo, and J. A. Yakichuk. 1992. Delayed clearance of postprandial chylomicrons and their remnants in the hypoalphalipoproteinemia and mild hypertriglyceridemia syndrome. Arterioscler. Thromb. 12: 1184-1190.
47. Patsch, J. R., S. Prasad, A. M. Gotto, Jr., and J. R. Patsch. 1987. High density lipoprotein2. Relationship of the plasma levels of this lipoprotein species to its composition, to the magnitude of post-prandial lipemia, and to the activities of lipoprotein lipase and hepatic lipase. J. Clin. Invest. 80: 341-347.
48. Patsch, J. R., J. B. Karlin, L. W. Scott, L. C. Smith, and A. M. Gotto, Jr. 1983. Inverse relationship between blood levels of high density lipoprotein subfraction 2 and magnitude of postprandial lipemia. Proc. Natl. Acad. Sci. USA. 80: 1449-1453.
49. Slyper, A. H. 1994. Low-density lipoprotein density and atherosclerosis. J. Am. Med. Assoc. 272: 305-308.
50. Austin, M. A., J. E. Hokanson, and J. D. Brunzell. 1994. Characterization of low-density lipoprotein subclasses: methodologic approaches and clinical relevance. [Review]. Curr. Opin. Lipidol. 5: 395-403.
51. Austin, M. A., and K. L. Edwards. 1996. Small, dense low density lipoproteins, the insulin resistance syndrome and noninsulin-dependent diabetes. [Review]. Curr. Opin. Lipidol. 7: 167-171.
52. Gerdes, C., R. M. Fisher, V. Nicaud, J. Boer, S. K. Humphries, P. J. Talmud, and O. Faergeman. 1997. Lipoprotein lipase variants D9N and N291S are associated with increased plasma triglyceride and lower high-density lipoprotein cholesterol concentrations: studies in the fasting and postprandial states: the European Atherosclerosis Research Studies. Circulation. 96: 733-740.
53. Dallongeville, J., S. Lussier-Cacan, and J. Davignon. 1992. Modulation of plasma triglyceride levels by apoE phenotype: a meta-analysis. J. Lipid Res. 33: 447-454.
54. Kuivenhoven, J. A., B. E. Groenemeyer, J. M. Boer, P. W. Reymer, R. Berghuis, T. Bruin, H. Jansen, J. C. Seidell, and J. J. P. Kastelein. 1997. Ser447stop mutation in lipoprotein lipase is associated with elevated HDL cholesterol levels in normolipidemic males. Arterioscler. Thmmb. Vasc. Biol. 17: 595-599.
55. Fisher, R. M., S. E. Humphries, and P. J. Talmud. 1997. Common variation in the lipoprotein lipase gene: effects on plasma lipids and risk of atherosclerosis. Atherosclerosis. 135: 145-159.
56. Peacock, R. E., A. Temple, V. Gudnason, M. Rosseneu, and S. E. Humphries. 1997. Variation at the lipoprotein lipase and apoliporotein AI-CIII gene loci are associated with fasting lipid and lipoprotein traits in a population sample from Iceland: interaction between genotype, gender, and smoking status. Genet. Epidemiol. 14: 265-282.
57. Hegele, R. A., S. Gahndi, J. H. Brunt, and P. W. Connelly. 1996. Restriction isotyping of the premature termination variant of lipoprotein lipase in Alberta Hutterites. Clin. Biochem. 29: 63-66.
58. Faustinella, F., A. Chang, J. P. Van Biervliet, M. Rosseneu, N. Vinaimont, L. C. Smith, S. H. Chen, and L. Chan. 1991. Catalytic triad residue mutation (Asp156 - Gly) causing familial lipoprotein lipase deficiency. Co-inheritance with a nonsense mutation (Ser447 - Ter) in a Turkish family [published erratum appears in J. Biol. Chem. 1992; 267: 7194]. J. Biol. Chem. 266: 14418-14424.
59. 447→a stop codon) in lipoprotein lipase contributes to a defect in lipid interface recognition in a case with type I hyperlipidemia. Biochem. Biophys. Res. Commun. 182: 70-77.
60. 410→ Val) leads to enzyme inactivation and familial chylomicronemia. J. Lipid Res. 35: 1552-1560.